COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM), Market Insights and Forecast to 2026

Publisher Name :
Date: 29-Jun-2020
No. of pages: 115
Inquire Before Buying

Human Hepatitis B Immunoglobulin (IM) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Hepatitis B Immunoglobulin (IM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Hepatitis B Immunoglobulin (IM) market is segmented into

- 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)

- 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)

- 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)

Segment by Application, the Human Hepatitis B Immunoglobulin (IM) market is segmented into

- Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)

- Unexpected Crowd of Hepatitis B Infection

- Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers

Regional and Country-level Analysis

The Human Hepatitis B Immunoglobulin (IM) market is analysed and market size information is provided by regions (countries).

The key regions covered in the Human Hepatitis B Immunoglobulin (IM) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Human Hepatitis B Immunoglobulin (IM) Market Share Analysis

Human Hepatitis B Immunoglobulin (IM) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Hepatitis B Immunoglobulin (IM) business, the date to enter into the Human Hepatitis B Immunoglobulin (IM) market, Human Hepatitis B Immunoglobulin (IM) product introduction, recent developments, etc.

The major vendors covered:

- Baxter

- CSL

- Bayer

- Grifols

- Octapharma

- Shanghai RAAS

- Hualan Biological

- China Biologic

- Tiantan Biologic

- Shuanglin Bio-pharmacy

- Sichuan Yuanda Shuyang

- Boya Bio-pharmaceutical

- Shanghai Institute of Biological

COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM), Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Hepatitis B Immunoglobulin (IM) Product Introduction
1.2 Market Segments
1.3 Key Human Hepatitis B Immunoglobulin (IM) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Type
1.4.2 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.4.3 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.4.4 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.5 Market by Application
1.5.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Application
1.5.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
1.5.3 Unexpected Crowd of Hepatitis B Infection
1.5.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.6 Coronavirus Disease 2019 (Covid-19): Human Hepatitis B Immunoglobulin (IM) Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Hepatitis B Immunoglobulin (IM) Industry
1.6.1.1 Human Hepatitis B Immunoglobulin (IM) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Hepatitis B Immunoglobulin (IM) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Hepatitis B Immunoglobulin (IM) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Estimates and Forecasts
2.1.1 Global Human Hepatitis B Immunoglobulin (IM) Revenue 2015-2026
2.1.2 Global Human Hepatitis B Immunoglobulin (IM) Sales 2015-2026
2.2 Human Hepatitis B Immunoglobulin (IM) Market Size by Region: 2020 Versus 2026
2.2.1 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Hepatitis B Immunoglobulin (IM) Competitor Landscape by Players
3.1 Human Hepatitis B Immunoglobulin (IM) Sales by Manufacturers
3.1.1 Human Hepatitis B Immunoglobulin (IM) Sales by Manufacturers (2015-2020)
3.1.2 Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Manufacturers (2015-2020)
3.2 Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers
3.2.1 Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers (2015-2020)
3.2.2 Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Hepatitis B Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Hepatitis B Immunoglobulin (IM) Revenue in 2019
3.2.5 Global Human Hepatitis B Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Hepatitis B Immunoglobulin (IM) Price by Manufacturers
3.4 Human Hepatitis B Immunoglobulin (IM) Manufacturing Base Distribution, Product Types
3.4.1 Human Hepatitis B Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Hepatitis B Immunoglobulin (IM) Product Type
3.4.3 Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin (IM) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size by Type (2015-2020)
4.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020)
4.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue by Type (2015-2020)
4.1.3 Human Hepatitis B Immunoglobulin (IM) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Type (2021-2026)
4.2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Type (2021-2026)
4.2.3 Human Hepatitis B Immunoglobulin (IM) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Hepatitis B Immunoglobulin (IM) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size by Application (2015-2020)
5.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020)
5.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue by Application (2015-2020)
5.1.3 Human Hepatitis B Immunoglobulin (IM) Price by Application (2015-2020)
5.2 Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Application (2021-2026)
5.2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Hepatitis B Immunoglobulin (IM) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Hepatitis B Immunoglobulin (IM) by Country
6.1.1 North America Human Hepatitis B Immunoglobulin (IM) Sales by Country
6.1.2 North America Human Hepatitis B Immunoglobulin (IM) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
6.3 North America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application
7 Europe
7.1 Europe Human Hepatitis B Immunoglobulin (IM) by Country
7.1.1 Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country
7.1.2 Europe Human Hepatitis B Immunoglobulin (IM) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
7.3 Europe Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Hepatitis B Immunoglobulin (IM) by Region
8.1.1 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region
8.1.2 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
8.3 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Hepatitis B Immunoglobulin (IM) by Country
9.1.1 Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country
9.1.2 Latin America Human Hepatitis B Immunoglobulin (IM) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
9.3 Central & South America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) by Country
10.1.1 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country
10.1.2 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
10.3 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description, Business Overview and Total Revenue
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Hepatitis B Immunoglobulin (IM) Products Offered
11.1.5 Baxter Recent Development
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description, Business Overview and Total Revenue
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Human Hepatitis B Immunoglobulin (IM) Products Offered
11.2.5 CSL Recent Development
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description, Business Overview and Total Revenue
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Human Hepatitis B Immunoglobulin (IM) Products Offered
11.3.5 Bayer Recent Development
11.4 Grifols
11.4.1 Grifols Corporation Information
11.4.2 Grifols Description, Business Overview and Total Revenue
11.4.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Grifols Human Hepatitis B Immunoglobulin (IM) Products Offered
11.4.5 Grifols Recent Development
11.5 Octapharma
11.5.1 Octapharma Corporation Information
11.5.2 Octapharma Description, Business Overview and Total Revenue
11.5.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Octapharma Human Hepatitis B Immunoglobulin (IM) Products Offered
11.5.5 Octapharma Recent Development
11.6 Shanghai RAAS
11.6.1 Shanghai RAAS Corporation Information
11.6.2 Shanghai RAAS Description, Business Overview and Total Revenue
11.6.3 Shanghai RAAS Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Products Offered
11.6.5 Shanghai RAAS Recent Development
11.7 Hualan Biological
11.7.1 Hualan Biological Corporation Information
11.7.2 Hualan Biological Description, Business Overview and Total Revenue
11.7.3 Hualan Biological Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Products Offered
11.7.5 Hualan Biological Recent Development
11.8 China Biologic
11.8.1 China Biologic Corporation Information
11.8.2 China Biologic Description, Business Overview and Total Revenue
11.8.3 China Biologic Sales, Revenue and Gross Margin (2015-2020)
11.8.4 China Biologic Human Hepatitis B Immunoglobulin (IM) Products Offered
11.8.5 China Biologic Recent Development
11.9 Tiantan Biologic
11.9.1 Tiantan Biologic Corporation Information
11.9.2 Tiantan Biologic Description, Business Overview and Total Revenue
11.9.3 Tiantan Biologic Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Products Offered
11.9.5 Tiantan Biologic Recent Development
11.10 Shuanglin Bio-pharmacy
11.10.1 Shuanglin Bio-pharmacy Corporation Information
11.10.2 Shuanglin Bio-pharmacy Description, Business Overview and Total Revenue
11.10.3 Shuanglin Bio-pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Products Offered
11.10.5 Shuanglin Bio-pharmacy Recent Development
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description, Business Overview and Total Revenue
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Hepatitis B Immunoglobulin (IM) Products Offered
11.1.5 Baxter Recent Development
11.12 Boya Bio-pharmaceutical
11.12.1 Boya Bio-pharmaceutical Corporation Information
11.12.2 Boya Bio-pharmaceutical Description, Business Overview and Total Revenue
11.12.3 Boya Bio-pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Boya Bio-pharmaceutical Products Offered
11.12.5 Boya Bio-pharmaceutical Recent Development
11.13 Shanghai Institute of Biological
11.13.1 Shanghai Institute of Biological Corporation Information
11.13.2 Shanghai Institute of Biological Description, Business Overview and Total Revenue
11.13.3 Shanghai Institute of Biological Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Shanghai Institute of Biological Products Offered
11.13.5 Shanghai Institute of Biological Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Hepatitis B Immunoglobulin (IM) Market Estimates and Projections by Region
12.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Regions 2021-2026
12.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Regions 2021-2026
12.2 North America Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
12.2.1 North America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
12.2.2 North America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
12.2.3 North America: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
12.3 Europe Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
12.3.1 Europe: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
12.3.2 Europe: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
12.3.3 Europe: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
12.5.2 Latin America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Hepatitis B Immunoglobulin (IM) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Hepatitis B Immunoglobulin (IM) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Human Hepatitis B Immunoglobulin (IM) Market Segments
Table 2. Ranking of Global Top Human Hepatitis B Immunoglobulin (IM) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
Table 5. Major Manufacturers of 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
Table 6. Major Manufacturers of 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
Table 7. COVID-19 Impact Global Market: (Four Human Hepatitis B Immunoglobulin (IM) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Human Hepatitis B Immunoglobulin (IM) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Human Hepatitis B Immunoglobulin (IM) Players to Combat Covid-19 Impact
Table 12. Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Application 2020-2026 (MT)
Table 13. Global Human Hepatitis B Immunoglobulin (IM) Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 14. Global Human Hepatitis B Immunoglobulin (IM) Sales by Regions 2015-2020 (MT)
Table 15. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Regions (2015-2020)
Table 16. Global Human Hepatitis B Immunoglobulin (IM) Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Human Hepatitis B Immunoglobulin (IM) Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers (2015-2020)
Table 19. Global Human Hepatitis B Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Human Hepatitis B Immunoglobulin (IM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin (IM) as of 2019)
Table 21. Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Human Hepatitis B Immunoglobulin (IM) Price (2015-2020) (USD/MT)
Table 24. Human Hepatitis B Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Human Hepatitis B Immunoglobulin (IM) Product Type
Table 26. Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin (IM) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 29. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Type (2015-2020)
Table 30. Global Human Hepatitis B Immunoglobulin (IM) Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Human Hepatitis B Immunoglobulin (IM) Revenue Share by Type (2015-2020)
Table 32. Human Hepatitis B Immunoglobulin (IM) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 34. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Application (2015-2020)
Table 35. North America Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 36. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 37. North America Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 39. North America Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 40. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 41. North America Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 42. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 43. Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 44. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 45. Europe Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 47. Europe Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 48. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 49. Europe Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 50. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region (2015-2020) (MT)
Table 52. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 56. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 58. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 59. Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 60. Latin America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 63. Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 64. Latin America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 65. Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 66. Latin America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 68. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020) (MT)
Table 72. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020) (MT)
Table 74. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Major Businesses
Table 77. Baxter Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Baxter Product
Table 79. Baxter Recent Development
Table 80. CSL Corporation Information
Table 81. CSL Description and Major Businesses
Table 82. CSL Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. CSL Product
Table 84. CSL Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Grifols Corporation Information
Table 91. Grifols Description and Major Businesses
Table 92. Grifols Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Grifols Product
Table 94. Grifols Recent Development
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Major Businesses
Table 97. Octapharma Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Octapharma Product
Table 99. Octapharma Recent Development
Table 100. Shanghai RAAS Corporation Information
Table 101. Shanghai RAAS Description and Major Businesses
Table 102. Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Shanghai RAAS Product
Table 104. Shanghai RAAS Recent Development
Table 105. Hualan Biological Corporation Information
Table 106. Hualan Biological Description and Major Businesses
Table 107. Hualan Biological Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Hualan Biological Product
Table 109. Hualan Biological Recent Development
Table 110. China Biologic Corporation Information
Table 111. China Biologic Description and Major Businesses
Table 112. China Biologic Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. China Biologic Product
Table 114. China Biologic Recent Development
Table 115. Tiantan Biologic Corporation Information
Table 116. Tiantan Biologic Description and Major Businesses
Table 117. Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Tiantan Biologic Product
Table 119. Tiantan Biologic Recent Development
Table 120. Shuanglin Bio-pharmacy Corporation Information
Table 121. Shuanglin Bio-pharmacy Description and Major Businesses
Table 122. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Shuanglin Bio-pharmacy Product
Table 124. Shuanglin Bio-pharmacy Recent Development
Table 125. Sichuan Yuanda Shuyang Corporation Information
Table 126. Sichuan Yuanda Shuyang Description and Major Businesses
Table 127. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Sichuan Yuanda Shuyang Product
Table 129. Sichuan Yuanda Shuyang Recent Development
Table 130. Boya Bio-pharmaceutical Corporation Information
Table 131. Boya Bio-pharmaceutical Description and Major Businesses
Table 132. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Boya Bio-pharmaceutical Product
Table 134. Boya Bio-pharmaceutical Recent Development
Table 135. Shanghai Institute of Biological Corporation Information
Table 136. Shanghai Institute of Biological Description and Major Businesses
Table 137. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Shanghai Institute of Biological Product
Table 139. Shanghai Institute of Biological Recent Development
Table 140. Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Regions (2021-2026) (MT)
Table 141. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Country (2021-2026) (MT)
Table 145. North America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Country (2021-2026) (MT)
Table 147. Europe: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Region (2021-2026) (MT)
Table 149. Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Country (2021-2026) (MT)
Table 151. Latin America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Country (2021-2026) (MT)
Table 153. Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Human Hepatitis B Immunoglobulin (IM) Players
Table 158. Human Hepatitis B Immunoglobulin (IM) Customers List
Table 159. Human Hepatitis B Immunoglobulin (IM) Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type in 2020 & 2026
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 6. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application in 2020 & 2026
Figure 7. Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
Figure 8. Unexpected Crowd of Hepatitis B Infection
Figure 9. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 10. Human Hepatitis B Immunoglobulin (IM) Report Years Considered
Figure 11. Global Human Hepatitis B Immunoglobulin (IM) Market Size 2015-2026 (US$ Million)
Figure 12. Global Human Hepatitis B Immunoglobulin (IM) Sales 2015-2026 (MT)
Figure 13. Global Human Hepatitis B Immunoglobulin (IM) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Figure 15. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region in 2019
Figure 16. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
Figure 17. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region in 2019
Figure 18. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Hepatitis B Immunoglobulin (IM) Revenue in 2019
Figure 20. Human Hepatitis B Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
Figure 22. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type in 2019
Figure 23. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Type (2015-2020)
Figure 24. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Type in 2019
Figure 25. Global Human Hepatitis B Immunoglobulin (IM) Market Share by Price Range (2015-2020)
Figure 26. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Figure 27. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 28. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Application (2015-2020)
Figure 29. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Application in 2019
Figure 30. North America Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 33. North America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 34. U.S. Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Human Hepatitis B Immunoglobulin (IM) Market Share by Type in 2019
Figure 39. North America Human Hepatitis B Immunoglobulin (IM) Market Share by Application in 2019
Figure 40. Europe Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 43. Europe Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 44. Germany Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Human
  • Xanthine Oxidase Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Xanthine Oxidase Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Xanthine Oxidase Inhibitor pipeline landscape is provided, which includes the topic Overview and Xanthine Oxidase Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Xanthine Oxidase Inhibitor commercial assessment and clinical as......
  • Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Wnt Signaling Pathway Inhibitor pipeline landscape is provided, which includes the topic Overview and Wnt Signaling Pathway Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Wnt Signaling Pathway Inhibitor commercial assess......
  • Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Gated Sodium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Gated Sodium Channel Blockers mechanism of action. The assessment part of the report embraces, in-depth Voltage-Gated Sodium Channel Bl......
  • Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent T-Type Calcium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Dependent T-Type Calcium Channel Blockers mechanism of action. The assessment part of the report embraces, in-d......
  • Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent Calcium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Dependent Calcium Channel Blockers mechanism of action. The assessment part of the report embraces, in-depth Voltage-Dependen......
  • Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist pipeline landscape is provided, which includes the topic Overview and Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist mechanism of action. The assessment part of the rep......
  • Viral RNA Polymerase Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Viral RNA Polymerase Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Viral RNA Polymerase Inhibitor pipeline landscape is provided, which includes the topic Overview and Viral RNA Polymerase Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Viral RNA Polymerase Inhibitor commercial assessment......
  • VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor pipeline landscape is provided, which includes the topic Overview and VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor mechanism of......
  • Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Vasopressin V2 Receptor (V2R) Antagonist pipeline landscape is provided, which includes the topic Overview and Vasopressin V2 Receptor (V2R) Antagonist mechanism of action. The assessment part of the report embraces, in-depth Vasopressin V2 Recepto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs